Novonix (NVNXF) Operating Expenses (2022 - 2024)

Novonix has reported Operating Expenses for 3 years, with the latest figure at -$11.5 million in Q4 2024.

• For the quarter ending Q4 2024, Operating Expenses rose 4.42% year-over-year to -$11.5 million; the trailing twelve-month figure through Dec 2025 stood at -$11.5 million (up 51.13% YoY), and the FY2025 full-year result was -$18.3 million, down 13.41% from the prior year.
• Operating Expenses for Q4 2024 stood at -$11.5 million, up from -$12.1 million in the prior quarter.
• The five-year high for Operating Expenses was -$11.5 million in Q4 2024, with the low at -$12.1 million in Q4 2023.
• Historically, Operating Expenses has averaged -$11.9 million across 3 years, with a median of -$12.0 million in 2022.
• The largest YoY upside for Operating Expenses was 4.42% in 2024 against a maximum downside of 4.42% in 2024.
• Novonix's Operating Expenses stood at -$12.0 million in 2022, then declined by 0.8% to -$12.1 million in 2023, then gained by 4.42% to -$11.5 million in 2024.
• The last three Operating Expenses figures came in at -$11.5 million (Q4 2024), -$12.1 million (Q4 2023), and -$12.0 million (Q2 2022), per Business Quant data.